This offer is opportunistic I think there are definite synergies and 1+1 = 3 But SKE was $3.00+ within the last 12 months , pays a good dividend and strong brand. If the offer was reversed or loser to $2.00 where SKE kept 75% it might be ok
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025